The parathyroid hormone-related protein (PTHrP) gene: Use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis

Journal of Bone and Mineral Research

Volumn 14, Issue 3, 1999, Pages 406-414

  Bouizar, Zhor ^a   Spyratos, Frederique ^b   De Vernejoul, Marie Christine ^a  

^a CENTRE VIGGO PETERSEN   (France)

^b René Huguenin Cancer Institute   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN; TATA BINDING PROTEIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER RISK; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; PROMOTER REGION; RISK ASSESSMENT;

EID: 0033011428     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.3.406     Document Type: Article

References (38)

1. Galasko CSB 1969 The detection of skeletal metastases from mammary cancer by gamma camera scintigraphy. Br J Surg 56:757-764.
2. Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, Bennett RC, Martin TJ 1990 Immunohistochemical localization of parathyroid-hormone-related protein in human breast cancer. Cancer Res 50:7710-7716.
3. Brundred NJ, Walker RA, Ratcliffe WA, Warwick J, Morrison JM, Ratcliffe JG 1992 Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 28:690-692.
4. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, Martin TJ 1991 Parathyroid hormone-related protein: Elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73:1309-1315.
5. Vargas SJ, Gillespie MT, Powell GJ, Southby J, Danks JA, Moseley JM, Martin TJ 1992 Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 7:971-979.
6. Bouizar Z, Spyratos F, Deytieux S, de Vernejoul MC, Jullienne A 1993 Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer and occurrence of bone metastases. Cancer Res 53:5076-5078.
7. Yasuda T, Banville D, Hendy GN, Goltzman D 1989 Characterization of the human parathyroid hormone-like peptide gene. J Biol Chem 264:7720-7725.
8. Mangin M, Weeb AC, Dreayer BE, Posillico JT, Ikeda K, Weir E, Stewart AF, Bander NH, Milstone L, Barton Francke U, Broadus AE 1988 Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci USA 85:597-601.
9. Mangin M, Ikeda K, Dreyer B, Milstone L, Broadus AE 1989 Two distinct tumor-derived PTH-like peptides result from alternative I ribonucleic acid splicing. Mol Endocrinol 2:11049-11054.
10. Mangin M, Ikeda K, Dreyer BE, Broadus AE 1989 Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Natl Acad Sci USA 86:2408-2412.
11. Mangin M, Ikeda K, Dreyer BE, Broadus AE 1990 Identification of up-stream promoter of human parathyroid hormone-related peptide gene. Mol Endocrinol 4:851-858.
12. Vasavada RC, Wysolmerski JJ, Broadus AE, Phibrick WM 1993 Characterization of GC-rich promoter of human parathyroid hormone-related peptide gene. Mol Endocrinol 7:273-282.
13. Chilco PJ, Gerardi JM, Kaczmarczyk SJ, Chu S, Leopold V, Zajac JD 1990 Calcitonin increases transcription of parathyroid-hormone-related protein via cAMP. Mol Cell Endocrinol 94:1-7.
14. Campos RV, Zhang L, Drucker DJ 1992 Regulation of parathyroid hormone-related peptide (PTHrP) gene transcription: Cell-and tissue-specific promoter utilization mediated by multiple positive and negative cis-acting DNA elements. Mol Endocrinol 6:1642-1652.
15. Southby J, O'Keeffe LM, Martin TJ, Gillespie MT 1995 Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumors. Br J Cancer 72:702-707.
16. Southby J, Murphy LM, Martin TJ, Gillespie MT 1996 Cell-specific and regulator-induced promotor usage and messenger ribonucleic splicing for parathyroid hormone-related peptide. Endocrinology 137:1349-1357.
17. Heath JK, Southby J, Fucomoto S, O'Keeffe LM, Martin TJ, Gillepsie MT 1995 Epidermal growth factor-stimulated parathyroid-related protein expression involves increased gene transcription and mRNA stability. Biochem J 307:159-167.
18. Brandt DW, Wachasman W, Deftos LJ 1994 Parathyroid hormone-like protein: Alternative messenger RNA splicing pathways in human cancer cell lines. Cancer Res 54:850-853.
19. Scarff RW, Torloni H 1968 Histological Typing of Breast Tumors. World Health Organization, Genève, Switzerland, pp. 13-20.
20. Bloom HJ, Richardson WW 1957 Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377.
21. European Organization for Research and Treatment of Cancer (EORTC) 1980 Breast cancer cooperative group. Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16:1513-1515.
22. Chelly J, Kaplan JC, Maire P, Gautron S, Kahn A 1988 Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333:858-860.
23. Leonard MW, Engel JD, Papayannopoulou T 1993 Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 82:1071-1079.
24. Powel GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA 1991 Localization of parathyroid hormone-hormone protein in breast cancer metastasis: Increased incidence in bone compared with other sites. Cancer Res 51:3059-3061.
25. Orr FW, Mundy GR, Varani JG, Ward PA 1900 Chemotactic response to tumor cells to products of resorbing bone. Science 203:176-179.
26. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T, Mundy GR 1996 Evidence for a causal role of parathyroid-hormone-related protein in the pathogenesis of human breast cancer osteolysis. J Clin Invest 98:1544-1549.
27. Slamon D, Clark G, Wong S, Levin W, Ulrich A, Mc Guire W 1987 Human breast cancer: Correlation and survival with amplification of HER-2/neu oncogene. Science 235:177-182.
28. Liu C, Park M, Tsao M 1992 Overexpression of c-met protooncogene but not epidermal growth factor receptor or c-erb-B2 in primary human colorectal carcinoma. Oncogene 7:181-185.
29. Brandt DW, Bruns ME, Bruns DE, Ferguson IIJE, Burton DW, Deftos LJ 1992 The parathyroid hormone-related protein (PTHrP) gene preferentially utilizes a GC-rich promoter and the PTH 1-139 coding pathway in normal and human amnion. Biochem Biophys Res Commun 189:939-943.
30. Isognia KL, Stewart AF, Morris AF, Hough LM, Centrella M 1993 Native and synthetic analogue of the malignancy-associated parathyroid hormone-like protein have in vitro transforming growth factor-like peptide. J Clin Invest 83:1057-1060.
31. Hendersen J, Sebag M, Rhim J, Goltzman D, Kramer R 1991 Dysregulation of parathyroid-like peptide expression and secretion in a keratinocytes model of tumor progression. Cancer Res 51:6521-65228.
32. Thiede MA, Strewler GJ, Nissenson RA, Rosenbla M, Rodan GA 1988 Human renal carcinoma expression two messages encoding a parathyroid-hormone-like peptide: Evidence for the alternative splicing of a single-copy gene. Proc Natl Acad Sci USA 85:4605-5609.
33. Shaw G, Kramer RA 1986 Conserved AU-sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
34. Coleman RE, Rubens RD 1987 The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66.
35. Diel IJ, Kaufmann M, Goerner R, Costa SD, Bastert DG 1992 Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 10:1534-1539.
36. Kim SJ, Angel P, Lafyatis R, Hattori R, Kim K, Sporn MB, Karim M, Roberts AB 1990 Autoinduction of transforming growth factor b1 is mediated by the AP1 complex. Mol Cell Biol 10:1492-1497.
37. Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580.
38. Duffy MJ 1996 Proteases as prognostic markers in cancer. Clin Cancer Res 2:613-618.